These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy. Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296 [TBL] [Abstract][Full Text] [Related]
3. Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome. Thomas PD; Pollok RC; Gazzard BG HIV Med; 1999 Oct; 1(1):19-24. PubMed ID: 11737325 [TBL] [Abstract][Full Text] [Related]
4. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy. Deayton J; Mocroft A; Wilson P; Emery VC; Johnson MA; Griffiths PD AIDS; 1999 Jul; 13(10):1203-6. PubMed ID: 10416523 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus cell tropism and clinicopathological characteristics in gastrointestinal tract of patients with HIV/AIDS. Sun L; Chen JM; Yang K; Zhang L; Ma ZY; Chen XM; Li M; Zhou X; Li P; Zhao HX; Xiao J; Qi LM; Wang P Diagn Pathol; 2022 Jan; 17(1):9. PubMed ID: 35027044 [TBL] [Abstract][Full Text] [Related]
7. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Deayton JR; Prof Sabin CA; Johnson MA; Emery VC; Wilson P; Griffiths PD Lancet; 2004 Jun; 363(9427):2116-21. PubMed ID: 15220032 [TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors. Lin DY; Warren JF; Lazzeroni LC; Wolitz RA; Mansour SE Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458 [TBL] [Abstract][Full Text] [Related]
9. A clinico-pathological audit of opportunistic viral infections in HIV-infected patients. Pillay D; Lipman MC; Lee CA; Johnson MA; Griffiths PD; McLaughlin JE AIDS; 1993 Jul; 7(7):969-74. PubMed ID: 8395189 [TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus pseudotumor of the duodenum in a patient with AIDS: an unrecognized and potentially treatable clinical entity. Kelesidis T; Tozzi S; Mitty R; Worthington M; Fleisher J Int J Infect Dis; 2010 Apr; 14(4):e274-82. PubMed ID: 19695917 [TBL] [Abstract][Full Text] [Related]
11. The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment. Bigliano P; Calcagno A; Lucchini A; Audagnotto S; Montrucchio C; Marinaro L; Alcantarini C; Ghisetti V; Di Perri G; Bonora S Antivir Ther; 2018; 23(5):451-456. PubMed ID: 29372886 [TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus colitis in a human immunodeficiency virus-positive patient with a normal CD4 count. Paparone PP; Paparone PA Am J Med Sci; 2012 Dec; 344(6):508-10. PubMed ID: 22874621 [TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus colitis mimics amebic colitis in a man with AIDS. Wang YC; Lee HS; Lin TY; Wang NC Am J Med Sci; 2008 Oct; 336(4):362-4. PubMed ID: 18854684 [TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and T-lymphocyte subsets in 48 acquired immune deficiency syndrome patients with cytomegalovirus infections]. Jia CH; Wang L; Jing FH; Xie J; Qiu ZF; Li TS; Lyu W Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):191-197. PubMed ID: 30803177 [No Abstract] [Full Text] [Related]
15. Lessons learned from HIV pathogenesis and therapy: implications for better management of cytomegalovirus disease. Hardy WD AIDS; 1996 Nov; 10 Suppl 1():S31-5. PubMed ID: 8970674 [TBL] [Abstract][Full Text] [Related]
16. CMV as a cofactor enhancing progression of AIDS. Griffiths PD J Clin Virol; 2006 Apr; 35(4):489-92. PubMed ID: 16413825 [TBL] [Abstract][Full Text] [Related]
17. The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy. Varani S; Spezzacatena P; Manfredi R; Chiodo F; Mastroianni A; Ballarini P; Boschini A; Lazzarotto T; Landini MP Eur J Epidemiol; 2000 May; 16(5):433-7. PubMed ID: 10997830 [TBL] [Abstract][Full Text] [Related]
18. Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001. Yust I; Fox Z; Burke M; Johnson A; Turner D; Mocroft A; Katlama C; Ledergerber B; Reiss P; Kirk O; Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):550-9. PubMed ID: 15232720 [TBL] [Abstract][Full Text] [Related]
19. Mononeuritis multiplex: an uncommon neurological manifestation of cytomegalovirus reactivation in an HIV-infected patient. Palma P; Costa A; Duro R; Neves N; Abreu C; Sarmento A BMC Infect Dis; 2018 Nov; 18(1):554. PubMed ID: 30419847 [TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). Steininger C; Puchhammer-Stöckl E; Popow-Kraupp T J Clin Virol; 2006 Sep; 37(1):1-9. PubMed ID: 16675299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]